{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:25:52Z","timestamp":1781076352092,"version":"3.54.1"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Methylene blue (MB) has been routinely used to treat methemoglobinemia. In\nthe body, MB is reduced to leucomethylene blue (LMB) by NADPH-dependent methemoglobin\n(MetHB) reductase, and then LMB reduces Fe&lt;sup&gt;3+&lt;\/sup&gt; to Fe&lt;sup&gt;2+&lt;\/sup&gt;. In glucose-6-phosphate\ndehydrogenase (G6PD) deficiency, NADPH is not produced sufficiently to protect erythrocytes\nagainst oxidative stress and to take part in relevant biochemical reactions. Since\nMB is an oxidative agent, its administration in individuals with G6PD deficiency leads to\nan increased risk of hemolysis through oxidative stress and even death. Therefore, its administration\nhas been prohibited from treating methemoglobinemia in G6PD patients. As\nan antioxidant and direct reducing agent for Fe&lt;sup&gt;3+&lt;\/sup&gt;, LMB may be prescribed for treating\nMetHB in patients with G6PD deficiency. Considering the biochemical process of turning\nMB into LBM and the reducing nature of LMB, it seems LMB is a safer drug than MB in\ntreating methemoglobinemia. LMB can even be administrated in other treatments without\nany concern about increasing oxidative stress, exacerbating the inflammation. Proof-ofconcept\nexperimental and clinical trials could substantiate this hypothesis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230911113159","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T10:52:26Z","timestamp":1694429546000},"page":"1033-1039","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Potential of Leucomethylene Blue in Methemoglobinemia Treatment: A New Hope for Patients with G6PD?"],"prefix":"10.2174","volume":"32","author":[{"given":"Elaheh","family":"Emadi","sequence":"first","affiliation":[{"name":"Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryoush Hamidi","family":"Alamdari","sequence":"additional","affiliation":[{"name":"General Surgery Department, Surgical Oncology Research Center, Imam Reza Hospital, Mashhad\nUniversity of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.7326\/0003-4819-75-1-83","volume":"75","author":"Rosen P.J.","year":"1971","unstructured":"Rosen P.J.; Johnson C.; McGehee W.G.; Beutler E.; Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med  1971,75(1),83-86","journal-title":"Ann Intern Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e27904","DOI":"10.1097\/MD.0000000000027904","volume":"100","author":"Al-Dubai H.","year":"2021","unstructured":"Al-Dubai H.; Al-Mashdali A.; Hailan Y.; Acute hemolysis and methemoglobinemia secondary to fava beans ingestion in a patient with G6PD deficiency. Medicine  2021,100(47),e27904","journal-title":"Medicine"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/BF03016060","volume":"52","author":"Baraka A.S.","year":"2005","unstructured":"Baraka A.S.; Ayoub C.M.; Yazbeck-Karam V.; Kaddoum R.N.; Gerges F.J.; Hadi U.M.; Dagher C.M.; Prophylactic methylene blue in a patient with congenital methemoglobinemia. Can J Anaesth  2005,52(3),258-261","journal-title":"Can J Anaesth"},{"key":"ref=4","first-page":"223369","volume":"2018","author":"Rehman A.","year":"2018","unstructured":"Rehman A.; Shehadeh M.; Khirfan D.; Jones A.; Severe acute haemolytic anaemia associated with severe methaemoglobinaemia in a G6PD-deficient man. Case Reports  2018,2018,223369","journal-title":"Case Reports"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1590\/S0036-46651988000500007","volume":"30","author":"Barraviera B.","year":"1988","unstructured":"Barraviera B.; Machado P.E.A.; Meira D.A.; Curi P.R.; Martins J.N.P.; Souza M.J.; Glucose-6-phosphate dehydrogenase and glutathione reductase activity in methemoglobin reduction by methylene blue and cyst amine: Study on glucose-6-phosphate dehydrogenase-deficient individuals, on normal subjects and on riboflavin-treated subjects. Rev Inst Med Trop S\u00e3o Paulo  1988,30(5),370-378","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"ref=6","first-page":"626","volume":"55","author":"Hayes D.","year":"2010","unstructured":"Hayes D.; Roessler-Henderson K.M.; Davenport S.M.; Collins P.B.; Ballard H.O.; Dyspnea in a lung transplant recipient. Respir Care  2010,55(5),626-629","journal-title":"Respir Care"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/FPC.0b013e32836498f4","volume":"23","author":"McDonagh E.M.","year":"2013","unstructured":"McDonagh E.M.; Bautista J.M.; Youngster I.; Altman R.B.; Klein T.E.; PharmGKB summary. Pharmacogenet Genomics  2013,23(9),498-508","journal-title":"Pharmacogenet Genomics"},{"key":"ref=8","first-page":"1303","volume":"91","author":"Luzzatto L.","year":"2006","unstructured":"Luzzatto L.; Glucose 6-phosphate dehydrogenase deficiency: From genotype to phenotype. Haematologica  2006,91(10),1303-1306","journal-title":"Haematologica"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000187048","volume":"62","author":"Finielz P.","year":"1992","unstructured":"Finielz P.; Gendoo Z.; Lataste A.; Chuet C.; Guiserix J.; Methemoglobinemia and intravascular hemolysis in a patient with G6PD deficiency. Nephron J  1992,62(2),242-242","journal-title":"Nephron J"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"S1263","DOI":"10.14309\/01.ajg.0000711552.57537.97","volume":"115","author":"Kim K-Y.","year":"2020","unstructured":"Kim K-Y.; Tsai F.; Coyle W.; Skinner M.; S2376 Indocyanine Green (ICG) is a safe alternative to methylene blue in patients with G6PD deficiency undergoing endoscopic submucosal dissection. Am J Gastroenterol  2020,115,S1263-S1264","journal-title":"Am J Gastroenterol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2146\/ajhp160961","volume":"75","author":"Belfield K.D.","year":"2018","unstructured":"Belfield K.D.; Tichy E.M.; Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency. Am J Health Syst Pharm  2018,75(3),97-104","journal-title":"Am J Health Syst Pharm"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"8198565","DOI":"10.1155\/2018\/8198565","volume":"2018","author":"Benchimol M.","year":"2018","unstructured":"Benchimol M.; Madeira L.B.; de Oliveira-Souza R.; Late-life presentation of unsuspected G6PD deficiency. Case Rep Crit Care  2018,2018,8198565","journal-title":"Case Rep Crit Care"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5001\/omj.2014.33","volume":"29","author":"Hassan K.S.","year":"2014","unstructured":"Hassan K.S.; Al-Riyami A.Z.; Al-Huneini M.; Al-Farsi K.; Al-Khabori M.; Methemoglobinemia in an elderly patient with glucose-6-phosphate dehydrogenase deficiency: A case report. Oman Med J  2014,29(2),135-137","journal-title":"Oman Med J"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"Cappellini M.D.","year":"2008","unstructured":"Cappellini M.D.; Fiorelli G.; Glucose-6-phosphate dehydrogenase deficiency. Lancet  2008,371(9606),64-74","journal-title":"Lancet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5742\/MEWFM.2020.93862","volume":"18","author":"Sumathipala S.","year":"2020","unstructured":"Sumathipala S.; Glucose-6-phosphate dehydrogenase deficiency: A review. World Family Med. J. Middle East J Family Med  2020,18(9),92-97","journal-title":"Middle East J Family Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"876","DOI":"10.5694\/j.1326-5377.1974.tb93397.x","volume":"1","author":"Young G.P.","year":"1974","unstructured":"Young G.P.; Smith M.B.; Woodfield D.G.; Glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea using a simple methylene blue reduction test. Med J Aust  1974,1(22),876-878","journal-title":"Med J Aust"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00045391-200307000-00009","volume":"10","author":"Clifton J.","year":"2003","unstructured":"Clifton J.; Leikin J.B.; Methylene blue. Am J Ther  2003,10(4),289-291","journal-title":"Am J Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4103\/0975-7406.90112","volume":"3","author":"Sikka P.","year":"2011","unstructured":"Sikka P.; Bindra V.K.; Kapoor S.; Jain V.; Saxena K.K.; Blue cures blue but be cautious. J Pharm Bioallied Sci  2011,3(4),543-545","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e15232","DOI":"10.7759\/cureus.15232","volume":"13","author":"Laslett N.","year":"2021","unstructured":"Laslett N.; Hibbs J.; Hallett M.; Ghaneie A.; Zemba-Palko V.; Glucose-6-phosphate dehydrogenase deficiency-associated hemolytic anemia and methemoglobinemia in a patient treated with hydroxychloroquine in the era of COVID-19. Cureus  2021,13(5),e15232","journal-title":"Cureus"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/S0022-3468(03)00278-1","volume":"38","author":"Albert M.","year":"2003","unstructured":"Albert M.; Lessin M.S.; Gilchrist B.F.; Methylene blue: Dangerous dye for neonates. J Pediatr Surg  2003,38(8),1244-1245","journal-title":"J Pediatr Surg"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1553-2712.1998.tb02617.x","volume":"5","author":"Wright R.O.","year":"1998","unstructured":"Wright R.O.; Woolf A.D.; Shannon M.W.; Magnani B.; N-acetylcysteine reduces methemoglobin in an in vitro model of glucose-6-phosphate dehydrogenase deficiency. Acad Emerg Med  1998,5(3),225-229","journal-title":"Acad Emerg Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.EEM.0000292322.94148.37","volume":"23","author":"Greenberg M.I.","year":"2001","unstructured":"Greenberg M.I.; Methylene blue. Emer Med News  2001,23(9),26","journal-title":"Emer Med News"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"C1036","DOI":"10.1152\/ajpcell.00164.2003","volume":"285","author":"Liu X.","year":"2003","unstructured":"Liu X.; Spolarics Z.; Methemoglobin is a potent activator of endothelial cells by stimulating IL-6 and IL-8 production and E-selectin membrane expression. Am J Physiol Cell Physiol  2003,285(5),C1036-C1046","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ajh.20738","volume":"82","author":"Umbreit J.","year":"2007","unstructured":"Umbreit J.; Methemoglobin-It\u2019s not just blue: A concise review. Am J Hematol  2007,82(2),134-144","journal-title":"Am J Hematol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/0972-5229.130582","volume":"18","author":"Natarajan M.","year":"2014","unstructured":"Natarajan M.; James E.; Ebenezer K.; Ebenezer K.; Methylene blue unresponsive methemoglobinemia. Indian J Crit Care Med  2014,18(4),253-255","journal-title":"Indian J Crit Care Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3245935","DOI":"10.1155\/2016\/3245935","volume":"2016","author":"Panza F.","year":"2016","unstructured":"Panza F.; Solfrizzi V.; Seripa D.; Imbimbo B.P.; Lozupone M.; Santamato A.; Zecca C.; Barulli M.R.; Bellomo A.; Pilotto A.; Tau-centric targets and drugs in clinical development for the treatment of Alzheimer\u2019s disease. BioMed Res Int  2016,2016,3245935","journal-title":"BioMed Res Int"},{"key":"ref=27","first-page":"291","volume":"8","author":"Hamidi Alamdari D.","year":"2020","unstructured":"Hamidi Alamdari D.; Bagheri Moghaddam A.; Amini S.; Hamidi Alamdari A.; Damsaz M.; Yarahmadi A.; The application of a reduced dye used in orthopedics as a novel treatment against coronavirus (COVID-19): A suggested therapeutic protocol. Arch Bone Jt Surg  2020,8(Suppl. 1),291-294","journal-title":"Arch Bone Jt Surg"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.24875\/RIC.21000028","volume":"73","author":"Hamidi-Alamdari D.","year":"2021","unstructured":"Hamidi-Alamdari D.; Hafizi-Lotfabadi S.; Bagheri-Moghaddam A.; Safari H.; Mozdourian M.; Javidarabshahi Z.; Peivandi-Yazdi A.; Ali-Zeraati A.; Sedaghat A.; Poursadegh F.; Barazandeh-Ahmadabadi F.; Agheli-Rad M.; Tavousi S.M.; Vojouhi S.; Amini S.; Amini M.; Majid-Hosseini S.; Tavanaee-Sani A.; Ghiabi A.; Nabavi-Mahalli S.; Morovatdar N.; Rajabi O.; Koliakos G.; Methylene blue for treatment of hospitalized COVID-19 patients: A randomized, controlled, open-label clinical trial, phase 2. Rev Invest Clin  2021,73(3),190-198","journal-title":"Rev Invest Clin"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"C1390","DOI":"10.1152\/ajpcell.00512.2003","volume":"286","author":"May J.M.","year":"2004","unstructured":"May J.M.; Qu Z.; Cobb C.E.; Reduction and uptake of methylene blue by human erythrocytes. Am J Physiol Cell Physiol  2004,286(6),C1390-C1398","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ajh.20547","volume":"81","author":"Foltz L.M.","year":"2006","unstructured":"Foltz L.M.; Dalal B.I.; Wadsworth L.D.; Broady R.; Chi K.; Eisenhauer E.; Kobayashi K.; Kollmannsburger C.; Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine. Am J Hematol  2006,81(3),210-211","journal-title":"Am J Hematol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2141.2005.05404.x","volume":"129","author":"Dalal B.I.","year":"2005","unstructured":"Dalal B.I.; Kollmannsberger C.; Drug-induced haemolysis and methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency. Br J Haematol  2005,129(3),291-291","journal-title":"Br J Haematol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/1520-6661(200007\/08)9:4<252::AID-MFM14>3.0.CO;2-U","volume":"9","author":"Gauthier T.W.","year":"2000","unstructured":"Gauthier T.W.; Methylene blue-induced hyperbilirubinemia in neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency. J Matern Fetal Med  2000,9(4),252-254","journal-title":"J Matern Fetal Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/(SICI)1098-1101(1998)13:1<28::AID-JCA6>3.0.CO;2-B","volume":"13","author":"Golden P.J.","year":"1998","unstructured":"Golden P.J.; Weinstein R.; Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange. J Clin Apher  1998,13(1),28-31","journal-title":"J Clin Apher"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/0310057X0703500222","volume":"35","author":"Mullick P.","year":"2007","unstructured":"Mullick P.; Kumar A.; Dayal M.; Babbar S.; Kumar A.; Aniline-induced methaemoglobinaemia in a glucose-6-phosphate dehydrogenase enzyme deficient patient. Anaesth Intensive Care  2007,35(2),286-288","journal-title":"Anaesth Intensive Care"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1460-9592.2004.01420.x","volume":"15","author":"Maddali M.M.","year":"2005","unstructured":"Maddali M.M.; Fahr J.; Postoperative methemoglobinemia with associated G-6-P-D deficiency in infant cardiac surgery - enigmas in diagnosis and management. Paediatr Anaesth  2005,15(4),334-337","journal-title":"Paediatr Anaesth"},{"key":"ref=36","first-page":"321","volume":"46","author":"Yang C-C.","year":"2004","unstructured":"Yang C-C.; Wu M-L.; Deng J-F.; Prolonged hemolysis and methemoglobinemia following organic copper fungicide ingestion. Vet Hum Toxicol  2004,46(6),321-323","journal-title":"Vet Hum Toxicol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/annonc\/mdr490","volume":"23","author":"Vadhan-Raj S.","year":"2012","unstructured":"Vadhan-Raj S.; Fayad L.E.; Fanale M.A.; Pro B.; Rodriguez A.; Hagemeister F.B.; Bueso-Ramos C.E.; Zhou X.; McLaughlin P.W.; Fowler N.; Shah J.; Orlowski R.Z.; Samaniego F.; Wang M.; Cortes J.E.; Younes A.; Kwak L.W.; Sarlis N.J.; Romaguera J.E.; A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome. Ann Oncol  2012,23(6),1640-1645","journal-title":"Ann Oncol"},{"key":"ref=38","first-page":"3","volume":"1426","author":"Kang S.","year":"2012","unstructured":"Kang S.; Methaemoglobinaemia in a patient with G6PD deficiency: Case report. Reactions  2012,1426,3","journal-title":"Reactions"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/pbc.21582","volume":"51","author":"Bhat P.","year":"2008","unstructured":"Bhat P.; Collier A.B.; Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient. Pediatr Blood Cancer  2008,51(4),568","journal-title":"Pediatr Blood Cancer"},{"key":"ref=40","first-page":"659","volume":"86","author":"Karadsheh N.S.","year":"2001","unstructured":"Karadsheh N.S.; Shaker Q.; Ratroat B.; Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: Failure of methylene blue treatment. Haematologica  2001,86(6),659-660","journal-title":"Haematologica"},{"key":"ref=41","first-page":"19","volume":"44","author":"Liao Y-P.","year":"2002","unstructured":"Liao Y-P.; Hung D-Z.; Yang D-Y.; Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia. Vet Hum Toxicol  2002,44(1),19-21","journal-title":"Vet Hum Toxicol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1399-6576.1998.tb05173.x","volume":"42","author":"Bilgin H.;","year":"1998","unstructured":"Bilgin H.;; \u00d6zcan, B.; Bilgin, T. Methemoglobinemia induced by methylene blue pertubation during laparoscopy. Acta Anaesthesiol Scand  1998,42(5),594-595","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4103\/ijn.IJN_316_16","volume":"27","author":"Balwani M.R.","year":"2017","unstructured":"Balwani M.R.; Bawankule C.P.; Ramteke V.; Tolani P.; Vakil S.; Yadav R.; Methylene blue induced methemoglobinemia with acute kidney injury in a glucose-6-phosphate dehydrogenase-deficient patient. Indian J Nephrol  2017,27(6),465-467","journal-title":"Indian J Nephrol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/pds.3370","volume":"22","author":"M\u00fcller O.","year":"2013","unstructured":"M\u00fcller O.; Mockenhaupt F.P.; Marks B.; Meissner P.; Coulibaly B.; Kuhnert R.; Buchner H.; Schirmer R.H.; Walter-Sack I.; Si\u00e9 A.; Mansmann U.; Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: A synopsis of four RCTs. Pharmacoepidemiol Drug Saf  2013,22(4),376-385","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref=45","first-page":"151","volume":"4","author":"Shim J-Y.","year":"2006","unstructured":"Shim J-Y.; Seo Y-S.; Yang J-O.; Lee E-Y.; Hong S-Y.; Gil H-W.; A fatal case of methylene blue threatment failure in methemoglobinemia. J Korean Soc Clin Toxicol  2006,4(2),151-154","journal-title":"J Korean Soc Clin Toxicol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-3156.2004.01356.x","volume":"10","author":"Mandi G.","year":"2005","unstructured":"Mandi G.; Witte S.; Meissner P.; Coulibaly B.; Mansmann U.; Rengelshausen J.; Schiek W.; Jahn A.; Sanon M.; W\u00fcst K.; Walter-Sack I.; Mikus G.; Burhenne J.; Riedel K.D.; Schirmer H.; Kouyat\u00e9 B.; M\u00fcller O.; Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural burkina faso. Trop Med Int Health  2005,10(1),32-38","journal-title":"Trop Med Int Health"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2165\/11597790-000000000-00000","volume":"35","author":"M\u00fcller O.","year":"2012","unstructured":"M\u00fcller O.; Meissner P.; Mansmann U.; Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue. Drug Saf  2012,35(1),85","journal-title":"Drug Saf"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1475-2875-4-45","volume":"4","author":"Meissner P.E.","year":"2005","unstructured":"Meissner P.E.; Mandi G.; Witte S.; Coulibaly B.; Mansmann U.; Rengelshausen J.; Schiek W.; Jahn A.; Sanon M.; Tapsoba T.; Walter-Sack I.; Mikus G.; Burhenne J.; Riedel K.D.; Schirmer H.; Kouyat\u00e9 B.; M\u00fcller O.; Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso. [ISRCTN27290841]. Malar J  2005,4(1),45","journal-title":"Malar J"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/11536520-000000000-00000","volume":"33","author":"Youngster I.","year":"2010","unstructured":"Youngster I.; Arcavi L.; Schechmaster R.; Akayzen Y.; Popliski H.; Shimonov J.; Beig S.; Berkovitch M.; Medications and glucose-6-phosphate dehydrogenase deficiency: An evidence-based review. Drug Saf  2010,33(9),713-726","journal-title":"Drug Saf"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0196-0644(00)70056-4","volume":"35","author":"Tanen D.A.","year":"2000","unstructured":"Tanen D.A.; LoVecchio F.; Curry S.C.; Failure of intravenous N-Acetylcysteine to reduce methemoglobin produced by sodium nitrite in human volunteers: A randomized controlled trial. Ann Emerg Med  2000,35(4),369-373","journal-title":"Ann Emerg Med"},{"key":"ref=51","first-page":"3","volume":"81","author":"Kuwada G.","year":"2022","unstructured":"Kuwada G.; Murakami A.; Glaser D.W.; Ingraham S.E.; Purohit P.J.; Mothball Ingestion in the setting of G6PD deficiency causing severe hemolytic anemia, methemoglobinemia, and multiple organ failure in a toddler. Hawaii J Health Soc Welf  2022,81(1),3-5","journal-title":"Hawaii J Health Soc Welf"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230911113159","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220874\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230911113159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:58:27Z","timestamp":1740481107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220874\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230911113159","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}